Danny Kushlick - Is marijuana more dangerous today?

Danny Kushlick is director of Transform Drug Policy Foundation. A former drug counsellor in the criminal justice system, he founded Transform in 1996 after recognising that prohibition caused his clients more problems than their drug use.



Danny Kushlick is director of Transform Drug Policy Foundation. A former drug counsellor in the criminal justice system, he founded Transform in 1996 after recognising that prohibition caused his clients more problems than their drug use. Transform is the UK's leading campaign for an effective drug policy based on the legal regulation and control of drugs. He is a leading contributor to the drug law reform debate in the media, among policy-makers and in the NGO arena.

He is co-author of After the War on Drugs: Options for Control (2004). He is also a member of the executive council of the International Harm Reduction Association, and is a co-opted member of the Advisory Council of the British Society of Criminology. His criticism of the Independent on Sunday article - which claimed that marijuana today is more dangerous and therefore it should not be legalized - is available here.

Share

Related articles

Get a penalty for doing your job!

Budai Gyula is a public employee in Ózd (town in Hungary). His job is to keep the recycling bins in order. He received a penalty for 10.000 HUF for scavenging, while he was doing his job. He acted correctly by not acknowledging his supposed offence by his signature. If he had done so, he could not argue against the decision. Do not sign anything if you have not committed what you’re being charged for!

The Ibogaine Session

On Monday, May 12th, 2008, the Six O'Clock Show at the International Harm Reduction Conference in Barcelona hosted a ‘User’s Choice’ session on Ibogaine, supported by INPUD. The filmed and edited session is available, in four parts, below. It is worth your time!

Interview with Dagmar Hedrich at the Correlation European Conference

On: The Importance and impact of research and evidence base in the drug field. The interview was made at the Correlation European Conference 27 - 29 September, Sofia, Bulgaria